|
|
Chief
Editor -
Abdulrazak
Abyad
MD, MPH, MBA, AGSF, AFCHSE
.........................................................
Editorial
Office -
Abyad Medical Center & Middle East Longevity
Institute
Azmi Street, Abdo Center,
PO BOX 618
Tripoli, Lebanon
Phone: (961)-3-201901
Email:
Amc_lb@yahoo.com
aabyad@cyberia.net.lb
.........................................................
Publisher
-
Lesley
Pocock
medi+WORLD International
AUSTRALIA
Email:
lesleypocock@mediworld.com.au
publishermwi@gmail.com
.........................................................
Editorial
Enquiries -
abyad@cyberia.net.lb
.........................................................
Advertising
Enquiries -
lesleypocock@mediworld.com.au
.........................................................
While all
efforts have been made to ensure the accuracy
of the information in this journal, opinions
expressed are those of the authors and do not
necessarily reflect the views of The Publishers,
Editor or the Editorial Board. The publishers,
Editor and Editorial Board cannot be held responsible
for errors or any consequences arising from
the use of information contained in this journal;
or the views and opinions expressed. Publication
of any advertisements does not constitute any
endorsement by the Publishers and Editors of
the product advertised.
The contents
of this journal are copyright. Apart from any
fair dealing for purposes of private study,
research, criticism or review, as permitted
under the Australian Copyright Act, no part
of this program may be reproduced without the
permission of the publisher.
|
|
|
WFM
/ MEJFM October Issue 7, 2025 |
|
Neurobiology
of dementia
A
Abyad
Correspondence
A. Abyad, MD, MPH, MBA, DBA, AGSF
, AFCHSE
Consultant, Internal Medicine and
Geriatric, Dar Al Shifa Hospital,
Kuwait Chairman, Middle-East Academy
for Medicine of Aging.
President, Middle East & North
Africa Association on Aging &
Alzheimers
Coordinator, Middle-East Primary
Care Research Network
Coordinator, Middle-East Network
on Aging
Email: aabyad@cyberia.net.lb
Received: August 2025. Accepted:
September 2025; Published: October
2025.Citation: A. Abyad. Neurobiology
of dementia.. World Family Medicine.
October 2025; 23(7): 30 - 51
DOI: 10.5742/MEWFM.2025.805257903
Abstract
Dementia encompasses a group
of progressive neurodegenerative
disorders marked by cognitive,
behavioural, and functional
decline, underpinned by complex
neurobiological processes.
This chapter outlines the
anatomical, cellular, and
molecular mechanisms that
drive disease onset and progression.
Structural vulnerability of
the hippocampus, cerebral
cortex, white matter, and
cognitive networks underlies
characteristic clinical manifestations.
At the microscopic level,
neuro-inflammation, mitochondrial
dysfunction, oxidative stress,
excitotoxicity, impaired protein
clearance, and synaptic loss
converge to promote neuronal
injury. Distinct proteinopathiesincluding
amyloid- plaques and tau tangles
in Alzheimers disease,
-synuclein inclusions in Lewy
body dementia, and TDP-43
or tau aggregates in frontotemporal
lobar degenerationdefine
specific dementia subtypes,
yet share overlapping cascades
of pathology. Vascular contributions,
such as ischemia, hypoperfusion,
and bloodbrain barrier
disruption, further compound
neuronal vulnerability, highlighting
the prevalence of mixed dementias.
Collectively, these mechanisms
illustrate dementia as a multifactorial
disorder of network disintegration
and cellular stress. Advancing
insights into these processes
are driving the development
of biomarkers and disease-modifying
therapies, paving the way
for more precise, personalized
approaches to diagnosis and
care.
|
|
|
|
|
.................................................................................................................
|
|